Keywords: Alpharma, Promotion, False claims, Kadian, Pain drug

Alpharma to pay $42.5 million to resolve allegations on promotion of Kadian in the USA

Article | 17 March 2010

US drugmaker Alpharma, a subsidiary of King Pharmaceuticals, has agreed to pay $42.5 million to resolve False Claims Act allegations in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in